Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invitation to the presentation and Q&A of the interim report and year-end report 2020

  On the 23rd of February at 10:00 CET, Speqta will hold a meeting for shareholders, media and other stakeholders to present their interim report to be published for Q4 2020 and year-end report. Participants will be able to follow the presentation via webcast. CEO Fredrik Lindros will present the report, which will be followed by a Q&A session together with the CFO Adam Jonsson. There will be opportunities to ask questions via webcast, and presentation materials will be included.The interim report will be released on February 23rd at 07:00 CET. Time: Tuesday February

Crunchfish presents its year-end report - Solving for the future

On Thursday, February 18 at 08:30 CET / 13:00 IST, Crunchfish AB (“Crunchfish”) publishes its year-end report for 2020. During the day, Crunchfish is offering several opportunities to listen in to interviews and presentations about the report. When the report is released at 08:30 CET / 13:00 IST, an interview with Joachim Samuelsson by the Crunchfish’s IR & Marketing Manager will be published. This interview will be available both on the company’s website  as well as on our YouTube channel 

Nobia Capital Markets Day 2021

Nobia invites institutional investors, financial analysts and media to a virtual Capital Markets Day on March 25 when Jon Sintorn, President & CEO, and other members of Group management will provide further insight into Nobia’s strategy, operations and financial development. The event will be streamed on www.nobia.com/ir March 25 at 13:00 CET and will last around two hours, followed by a questions and answers session.Further information will be available on www.nobia.com/ir closer to the event.

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release February 16, 2021 at 10:20 a.m. Nokian Tyres has received an announcement from BlackRock, Inc. on February 15, 2021, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement, the total number of Nokian Tyres shares owned by BlackRock, Inc. and its funds fell below level of 5% of the share capital in Nokian Tyres plc, as a result of share transactions concluded on February 12, 2021. Total positions of BlackRock, Inc. and its funds subject to the notification: +----------------+----------+---------

Scandinavian Biogas' report for the fourth quarter and invitation to a conference call on February 18[th]

Scandinavian Biogas will publish the report for the fourth quarter of 2020 on Thursday, February 18 at approximately 12.00 A conference call for investors, analysts and the media will be held at 15.00 The report will be presented at the conference call by President and CEO Matti Vikkula and CFO Anna Budzynski. The presentation will be held in English and will begin with a short presentation of the report followed by a question-and-answer session. To participate in the conference call, use https://tv.streamfabriken.com/scandinavian-biogas or visit Scandinavian Biogas’s website, where

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 41 - 16 FEBRUAR 2021 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 90/2020. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information: Martin Badsted, CFO, tel.: +45 3315 0451

Cereno Scientific obtains patent protection in major market Japan for Phase II drug candidate CS1

Cereno Scientific today announced that drug candidate CS1 has obtained strengthened intellectual property rights (IPR) in Japan, one of the world’s largest pharmaceutical markets. The patent protection for CS1’s second patent family now covers key markets with previously granted markets, the US and Russia, as well as Japan. This adds to the growing portfolio of issued patents secured for Cereno’s assets to strengthen the commercial positioning.“Japan is one of the world’s largest pharmaceutical markets, only behind the US and marginally China. The patent protection for CS1 now covering two

Soil Scout announces new off-grid capable base station to deliver year-round sub-soil insights

The BST200 is easier to use, more powerful, and can be optimally positioned for rich sub-soil insights each seasonWireless underground soil monitoring solution Soil Scout  has announced the launch of their new off-grid capable BST200 Base Station. The BST200 has been specifically designed to give agriculture, golf, and sports turf maintenance professionals an uninterrupted view of their lands during the critical growing season months. “Customer feedback and satisfaction is an important part of Soil Scout's plan to continually improve the monitoring solutions on

A nationwide infrastructure of delivery boxes to be launched in Sweden

iBoxen, a company with the ambition to deploy a nationwide infrastructure of delivery boxes to pick up, return and ship packages, is now being launched. The new infrastructure will create sustainable  conditions for economic growth. iBoxen is ready to build the independent and national wide infrastructure for the delivery, return and shipping of parcels across Sweden supported by 2 large publicly traded propoerty investment companies - Fastighets AB Balder and SBB Norden AB. "An open and independent national infrastructure is a natural development step in supporting  e-commerce growth

Outokumpu joins an extensive research program to support journey towards carbon neutrality

Outokumpu OyjPress releaseFebruary 16, 2021 at 10.00 am EETOutokumpu joins an extensive research program to support journey towards carbon neutrality Outokumpu joins a three-year research program Towards Carbon Neutral Metals (TOCANEM) as a part of a consortium of multiple metal industry companies and universities in Finland. The research program is an important step in Outokumpu’s roadmap towards carbon neutrality. It enables Outokumpu to study and develop necessary technologies needed to reach ambitious climate targets and to support Outokumpu’s industry leading position in

Wärtsilä Combined Heat and Power plant helps Germany to reach its green energy goals

Wärtsilä Corporation, Trade press release, 16 February 2021 at 10 AM EETThe recently completed combined heat and power (CHP) plant  supplied by technology group Wärtsilä to Kraftwerke Mainz-Wiesbaden (KMW) in Germany has been officially handed over for commencement of commercial operations. The handover took place on 23 December, allowing municipal energy provider KMW to reliably provide 100 MW of electrical power. The CHP plant feeds the excess heat generated during power generation into the

Correction in the Group’s segment information published in 2020

Viking Line Abp   STOCK EXCHANGE RELEASE   16.02.2021, 10.00 AMDuring preparation of the Group’s Year-End Report, it was noted that incorrect segment information was reported in 2020. The correct segment information is presented in the table below.    Jan 1, 2020- Jan 1, 2020- Jan 1, 2020-EUR M Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 SalesVessels 151.6 95.7 73.5Unallocated 2.7 1.9 1.5Total, operating

Formpipe fourth quarter and full year 2020 results

PERIOD OCTOBER 1 – DECEMBER 31, 2020 · Net sales of SEK 103.4 m (SEK 103.1 m) · Software revenues of SEK 76.1 m (SEK 69.2 m) · Recurring revenues of SEK 67.2 m (SEK 59.0 m), which corresponds to 65 % (57 %) of net sales. · EBITDA SEK 25.9 m; 25.1 % (SEK 28.4 m; 27.5 %) · EBITDA-adj. SEK 14.1 m; 13.6 % (SEK 19.9 m; 19.4 %) · EBIT SEK 12.7 m; 12.3 % (SEK 15.3 m; 14.9 %) · Net profit SEK 12.0 m; 11.6 % (SEK 12.0 m; 11.7 %) · EPS before dilution SEK 0.22 (SEK 0.23) · Cash flow from operating activities SEK 49.6 m (SEK 48.1 m)     PERIOD JANUARY 1 – DECEMBER

Formpipe presents new growth strategy and financial targets

The software company Formpipe presents a new growth strategy and new financial targets when the company today publishes its fourth quarter and full year 2020 results. The new strategy captures opportunities to deliver on a number of markets with the self-developed and successful product Lasernet. ” Formpipe has a stable and profitable business for the public sector, a strong organization and high-quality products that meet an increasing demand as digitalization progresses. With an average annual sales growth exceeding 12 percent since 2016, Lasernet is an important part of Formpipe's

Indutrade acquires Dutch specialist in stirring and mixing technology

Indutrade has on 15 February signed an agreement to acquire all of the shares in the Dutch Typhoon Group, www.typhoongroup.eu with annual sales of approximately EUR 4.2 million. The agreement was signed after the market closed.Typhoon Group is a highly focused supplier of stirring and mixing systems. The systems, which range from less complex agitators to advanced installations, mix raw materials and products for a wide range of industries, for example food and beverage, chemical, pharmaceutical, cosmetics, wastewater, rubber and plastics industry. Typhoon’s offering includes customised

Apoteket AB starts selling Hydrocyn in Sweden

Sweden’s largest pharmacy Apoteket AB will start selling Bactiguard's disinfection solution Hydrocyn[®] aqua (Hydrocyn) and the products will initially be available via the online store www.apoteket.se. Hydrocyn is a non-alcoholic product that effectively kills virus, bacteria and fungi without irritating the skin.“Apoteket AB has a unique position in the Swedish market, both in terms of quality and customer service. The pandemic and the continued spread of virus and infections in society, means that there is a great need for products that are proven effective and at the same time work in

Klaria Pharma Holding AB (publ) issues notice to attend the annual general meeting

The shareholders in Klaria Pharma Holding AB (publ), reg. no. 556959-2917, are hereby given notice to attend the annual general meeting on 18 March 2021 at 10 a.m. (CET).Special arrangements due to the risk for spread of the virus COVID-19 (coronavirus) The board of directors has, in light of continued spread of the coronavirus and in accordance with the Swedish Act (2020:198) on temporary exceptions to facilitate the execution of general meetings in companies and other associations, decided that the annual general meeting shall be held without physical presence of shareholders, proxies

Axactor SE - Acceptances received under mandatory offer

THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Reference is made to the mandatory offer dated 29 January 2021 (the "Mandatory Offer") to acquire all shares in Axactor SE (the "Company") at an offer price of NOK 8.00 per share, made by Geveran Trading Co. Limited, a company indirectly controlled by trusts established by Mr. John Fredriksen for the benefit of his immediate family ("Geveran").  On 15 February 2021,

Notice to the Annual General Meeting of Metso Outotec Corporation

Metso Outotec Corporation’s stock exchange release on February 16, 2021, at 09:15 a.m. EETNotice to the Annual General Meeting of Metso Outotec Corporation Notice is given to the shareholders of Metso Outotec Corporation (“Metso Outotec” or the “Company”) to the Annual General Meeting (the “General Meeting”) to be held on April 23, 2021 at 2.00 p.m. (EEST) at Sanomatalo at the address Töölönlahdenkatu 2, FI-00100 Helsinki, Finland. The Company’s Board of Directors has resolved on exceptional meeting procedures based on the temporary legislative act to limit the spread of the Covid-19

Arctic Bioscience announces private placement and intention to list on Euronext Growth Oslo

The Norwegian biotechnology company developing a novel treatment for mild-to-moderate psoriasis, has engaged ABG Sundal Collier ASA and DNB Markets as joint global coordinators and joint bookrunners to advise on and effect a contemplated private placement raising gross proceeds of NOK 250 million and admission to trading of the Company’s shares on Euronext Growth Oslo.NOT FOR DISTRIBUTION, RELEASE OR REPUBLICATION, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE

Publication of Altia’s Financial Statements Bulletin 2020 on 25 February 2021 and invitation to a results presentation

Altia Plc  Press release  16 February 2020 at 9:00 am EET Publication of Altia’s Financial Statements Bulletin 2020 on 25 February 2021 and invitation to a results presentation Altia will publish its Financial Statements Bulletin 2020 on Thursday 25 February 2021 at around 8:30 am EET. CEO Pekka Tennilä and interim CFO Juhana Jokinen will present the report on the same day at 11:00 am EET. The presentation will be held as a Microsoft Teams Meeting. We recommend that participants join the event using the online meeting option: Join meeting here 

Africa Energy to Present at SpareBank 1 Markets Energy Conference

VANCOUVER, BC, February 16, 2021 /CNW/ - Africa Energy Corp. (TSX Venture: AFE) (Nasdaq First North: AEC) (“Africa Energy” or the “Company”), an oil and gas company with exploration assets offshore South Africa and Namibia, announces that the Company’s President and Chief Executive Officer, Garrett Soden, will be presenting at the SpareBank 1 Markets 2021 Digital Energy Conference on Wednesday, February 17, 2021, at approximately 12:30pm Central European Time. Investors can watch a live webcast of the presentation by registering for the conference at: https://sb1menergyconference.com/

Quarterly Report Q4 2020: Mangoral shows high diagnostic value in new study

Ascelia Pharma AB (publ) (ticker: ACE) today published its quarterly financial report for Q4 2020 (October – December 2020), which is now available on the company’s website: https://www.ascelia.com/ir-media/reports-presentations/SIGNIFICANT EVENTS IN Q4 2020 · Upgraded estimate of the addressable market for Mangoral to $500-600 million annually (previously $350-500 million) · New study showing that Mangoral’s lesion visualization is as effective as gadolinium · US patent for second generation Mangoral SIGNIFICANT EVENTS AFTER THE PERIOD · Presentation of clinical

Year-end report January-December 2020

Long-term profitable growth - before, during and after the pandemicFourth quarter · Net sales amounted to MSEK 93.1 (81.8), rendering a net sales growth of 14% (19%). Organic net sales growth was 13% (14%) · Recurring revenue amounted to MSEK 50.5 (44.3) · The quarter was impacted by one-off items affecting comparison, relating to writing-down a share option liability for part of the remaining shares in Lime Intenz AB, amounting to MSEK 1.4 (0.0) · Adjusted EBITA amounted to MSEK 29.3 (19.9) which corresponds to an adjusted EBITA margin of 31% (24%) · Net income amounted to

There are no items matching the current filter
There are no more items matching the current filter
Back to top